Glucocorticoid	B-protein
receptor	I-protein
concentrations	O
and	O
terminal	O
transferase	B-protein
activity	O
as	O
indicators	O
of	O
prognosis	O
in	O
acute	O
non-lymphocytic	O
leukaemia	O
.	O

Activity	O
of	O
terminal	B-protein
deoxynucleotidyl	I-protein
transferase	I-protein
(	O
TdT	B-protein
)	O
,	O
adenosine	B-protein
deaminase	I-protein
,	O
and	O
5'nucleotidase	B-protein
and	O
the	O
cellular	O
concentration	O
of	O
glucocorticoid	B-protein
(	I-protein
dexamethasone	I-protein
)	I-protein
receptor	I-protein
were	O
determined	O
in	O
25	O
patients	O
with	O
acute	O
non-lymphocytic	O
leukaemia	O
.	O

All	O
patients	O
were	O
treated	O
according	O
to	O
a	O
common	O
protocol	O
.	O

Increased	O
activity	O
of	O
TdT	B-protein
(	O
greater	O
than	O
0.1	O
unit/microgram	O
DNA	O
)	O
was	O
found	O
in	O
11	O
patients	O
.	O

This	O
group	O
of	O
patients	O
was	O
shown	O
to	O
have	O
higher	O
remission	O
and	O
survival	O
rates	O
(	O
p	O
=	O
0.06	O
)	O
compared	O
with	O
patients	O
with	O
low	O
activity	O
of	O
TdT	O
.	O

The	O
glucocorticoid	B-protein
receptor	I-protein
concentration	O
of	O
the	O
leukaemic	B-cell_type
blast	I-cell_type
cells	I-cell_type
ranged	O
from	O
0	O
to	O
0.94	O
fmol/microgram	O
DNA	O
.	O

Thirteen	O
patients	O
had	O
blast	B-cell_type
cells	I-cell_type
with	O
a	O
glucocorticoid	B-protein
receptor	I-protein
concentration	O
over	O
0.22	O
fmol/microgram	O
DNA	O
.	O

These	O
patients	O
had	O
significantly	O
increased	O
remission	O
and	O
survival	O
rates	O
(	O
p	O
=	O
0.006	O
)	O
compared	O
with	O
those	O
with	O
a	O
low	O
receptor	O
concentration	O
.	O

This	O
finding	O
can	O
not	O
be	O
explained	O
by	O
a	O
difference	O
in	O
sensitivity	O
to	O
glucocorticoids	O
since	O
these	O
were	O
not	O
used	O
as	O
therapeutic	O
agents	O
.	O

Adenosine	B-protein
deaminase	I-protein
and	O
5'nucleotidase	B-protein
activities	O
both	O
varied	O
within	O
two	O
orders	O
of	O
magnitude	O
.	O

No	O
correlation	O
could	O
be	O
found	O
between	O
activities	O
of	O
these	O
enzymes	O
and	O
remission	O
or	O
survival	O
rate	O
.	O

These	O
results	O
show	O
that	O
measurements	O
of	O
TdT	B-protein
activity	O
and	O
the	O
glucocorticoid	B-protein
receptor	I-protein
concentration	O
yield	O
valuable	O
prognostic	O
information	O
in	O
acute	O
non-lymphocytic	O
leukaemia	O

1826	NULL
BRITISH	NULL
MEDICAL	NULL
JOURNAL	NULL
-	NULL
VOLUME	NULL
282	NULL
6	NULL
junE	NULL
1981	NULL
Glucocorticoid	NULL
receptor	NULL
concentrations	NULL
and	NULL
terminal	NULL
transferase	NULL
activity	NULL
as	NULL
indicators	NULL
of	NULL
prognosis	NULL
in	NULL
acute	NULL
non-lymphocytic	NULL
leukaemia	NULL
LAMBERT	NULL
SKOOG	NULL
,	NULL
BO	NULL
NORDENSKJOLD	NULL
,	NULL
AKE	NULL
OST	NULL
,	NULL
BORJE	NULL
ANDERSSON	NULL
,	NULL
ROBERT	NULL
HAST	NULL
,	NULL
NICOLOUS	NULL
GIANNOULIS	NULL
,	NULL
SOLVEIG	NULL
HUMLA	NULL
,	NULL
TORSTEN	NULL
HAGERSTROM	NULL
,	NULL
PETER	NULL
REIZENSTEIN	NULL
Abstract	NULL
Activity	NULL
of	NULL
terminal	NULL
deoxynucleotidyl	NULL
transferase	NULL
(	NULL
TdT	NULL
)	NULL
,	NULL
adenosine	NULL
deaminase	NULL
,	NULL
and	NULL
5'nucleotidase	NULL
and	NULL
the	NULL
cellular	NULL
concentration	NULL
of	NULL
glucocorticoid	NULL
(	NULL
dexamethasone	NULL
)	NULL
receptor	NULL
were	NULL
determined	NULL
in	NULL
25	NULL
patients	NULL
with	NULL
acute	NULL
non-lymphocytic	NULL
leukaemia	NULL
.	NULL

All	NULL
patients	NULL
were	NULL
treated	NULL
according	NULL
to	NULL
a	NULL
common	NULL
protocol	NULL
.	NULL

Increased	NULL
activity	NULL
of	NULL
TdT	NULL
(	NULL
>	NULL
0-1	NULL
unit/ug	NULL
DNA	NULL
)	NULL
was	NULL
found	NULL
in	NULL
11	NULL
patients	NULL
.	NULL

This	NULL
group	NULL
of	NULL
patients	NULL
was	NULL
shown	NULL
to	NULL
have	NULL
higher	NULL
remission	NULL
and	NULL
survival	NULL
rates	NULL
(	NULL
p=0-06	NULL
)	NULL
compared	NULL
with	NULL
patients	NULL
with	NULL
low	NULL
activity	NULL
of	NULL
TdT	NULL
.	NULL

The	NULL
glucocorticoid	NULL
receptor	NULL
concentration	NULL
of	NULL
the	NULL
leukaemic	NULL
blast	NULL
cells	NULL
ranged	NULL
from	NULL
0	NULL
to	NULL
0-94	NULL
fmol/ug	NULL
DNA	NULL
.	NULL

Thirteen	NULL
patients	NULL
had	NULL
blast	NULL
cells	NULL
with	NULL
a	NULL
glucocorticoid	NULL
receptor	NULL
concentration	NULL
over	NULL
022	NULL
fmol/ug	NULL
DNA	NULL
.	NULL

These	NULL
patients	NULL
had	NULL
significantly	NULL
increased	NULL
remission	NULL
and	NULL
survival	NULL
rates	NULL
(	NULL
p=0-006	NULL
)	NULL
compared	NULL
with	NULL
those	NULL
with	NULL
a	NULL
low	NULL
receptor	NULL
concentration	NULL
.	NULL

This	NULL
finding	NULL
can	NULL
not	NULL
be	NULL
explained	NULL
by	NULL
a	NULL
difference	NULL
in	NULL
sensitivity	NULL
to	NULL
glucocorticoids	NULL
since	NULL
these	NULL
were	NULL
not	NULL
used	NULL
as	NULL
therapeutic	NULL
agents	NULL
.	NULL

Adenosine	NULL
deaminase	NULL
and	NULL
5'nucleotidase	NULL
activities	NULL
both	NULL
varied	NULL
within	NULL
two	NULL
orders	NULL
of	NULL
magnitude	NULL
.	NULL

No	NULL
correlation	NULL
could	NULL
be	NULL
found	NULL
between	NULL
activities	NULL
of	NULL
these	NULL
enzymes	NULL
and	NULL
remission	NULL
or	NULL
survival	NULL
rate	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
measurements	NULL
of	NULL
TdT	NULL
activity	NULL
and	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
concentration	NULL
yield	NULL
valuable	NULL
prognostic	NULL
information	NULL
in	NULL
acute	NULL
non-lymphocytic	NULL
leukaemia	NULL
.	NULL

Introduction	NULL
Immunological	NULL
and	NULL
cytochemical	NULL
classification	NULL
of	NULL
subgroups	NULL
in	NULL
acute	NULL
leukaemia	NULL
has	NULL
in	NULL
the	NULL
past	NULL
few	NULL
years	NULL
raised	NULL
the	NULL
hope	NULL
of	NULL
more	NULL
accurate	NULL
diagnosis	NULL
and	NULL
differentiated	NULL
treatment	NULL
.	NULL

Moreover	NULL
,	NULL
biochemical	NULL
studies	NULL
have	NULL
identified	NULL
marker	NULL
enzymes	NULL
that	NULL
will	NULL
aid	NULL
in	NULL
the	NULL
subclassification	NULL
of	NULL
acute	NULL
leukaemia	NULL
.	NULL

At	NULL
present	NULL
two	NULL
such	NULL
enzyme	NULL
markers	NULL
,	NULL
terminal	NULL
deoxynucleotidyl	NULL
transferase	NULL
(	NULL
TIT	NULL
)	NULL
and	NULL
hexosaminidase	NULL
,	NULL
appear	NULL
to	NULL
be	NULL
of	NULL
definite	NULL
value	NULL
.	NULL

In	NULL
children	NULL
the	NULL
activity	NULL
of	NULL
TdT	NULL
is	NULL
high	NULL
in	NULL
the	NULL
T	NULL
and	NULL
common	NULL
type	NULL
of	NULL
acute	NULL
lymphocytic	NULL
leukaemia	NULL
(	NULL
non-T-non-B	NULL
)	NULL
,	NULL
while	NULL
patients	NULL
with	NULL
B-cell-derived	NULL
leukaemias	NULL
have	NULL
low	NULL
activity	NULL
of	NULL
the	NULL
enzyme	NULL
.	NULL
'	NULL

Isoenzyme	NULL
analysis	NULL
of	NULL
hexosaminidase	NULL
has	NULL
shown	NULL
that	NULL
``	NULL
common	NULL
acute	NULL
lymphocytic	NULL
leukaemia	NULL
``	NULL
in	NULL
children	NULL
has	NULL
a	NULL
distinct	NULL
and	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
Karolinska	NULL
Hospital	NULL
,	NULL
Stockholm	NULL
,	NULL
Sweden	NULL
LAMBERT	NULL
SKOOG	NULL
,	NULL
mp	NULL
,	NULL
rHp	NULL
AKE	NULL
OST	NULL
,	NULL
mp	NULL
SOLVEIG	NULL
HUMLA	NULL
,	NULL
ta	NULL
TORSTEN	NULL
HAGERSTROM	NULL
,	NULL
ta	NULL
Department	NULL
of	NULL
Radiumhemmet	NULL
,	NULL
Karolinska	NULL
Hospital	NULL
BO	NULL
NORDENSKJOLD	NULL
,	NULL
mp	NULL
,	NULL
pup	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Division	NULL
of	NULL
Haematology	NULL
,	NULL
Karolinska	NULL
Hospital	NULL
BORJE	NULL
ANDERSSON	NULL
,	NULL
mp	NULL
,	NULL
rup	NULL
ROBERT	NULL
HAST	NULL
,	NULL
mp	NULL
,	NULL
rup	NULL
NICOLOUS	NULL
GIANNOULIS	NULL
,	NULL
mp	NULL
PETER	NULL
REIZENSTEIN	NULL
,	NULL
MD	NULL
,	NULL
PHD	NULL
easily	NULL
identifiable	NULL
pattern	NULL
.	NULL
``	NULL

Accordingly	NULL
,	NULL
measurements	NULL
of	NULL
the	NULL
cellular	NULL
TdT	NULL
activity	NULL
and	NULL
hexosaminidase	NULL
isoenzyme	NULL
pattern	NULL
will	NULL
subclassify	NULL
acute	NULL
lymphocytic	NULL
leukaemia	NULL
as	NULL
being	NULL
of	NULL
the	NULL
T	NULL
,	NULL
B	NULL
,	NULL
or	NULL
common	NULL
type	NULL
.	NULL

Since	NULL
common	NULL
acute	NULL
lymphocytic	NULL
leukaemia	NULL
in	NULL
children	NULL
has	NULL
a	NULL
much	NULL
better	NULL
prognosis	NULL
than	NULL
acute	NULL
lymphocytic	NULL
leukaemia	NULL
of	NULL
T-	NULL
or	NULL
B-cell	NULL
origin	NULL
analysis	NULL
of	NULL
hexosaminidase	NULL
and	NULL
TdT	NULL
activity	NULL
obviously	NULL
has	NULL
great	NULL
practical	NULL
implications	NULL
.	NULL

Activity	NULL
of	NULL
TdT	NULL
is	NULL
generally	NULL
low	NULL
in	NULL
acute	NULL
non-lymphocytic	NULL
leukaemia	NULL
,	NULL
although	NULL
occasional	NULL
cases	NULL
of	NULL
acute	NULL
myeloblastic	NULL
leukaemia	NULL
with	NULL
raised	NULL
TdT	NULL
activity	NULL
have	NULL
been	NULL
reported	NULL
.	NULL

It	NULL
has	NULL
also	NULL
been	NULL
reported	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
detectable	NULL
TdT	NULL
activity	NULL
in	NULL
blast	NULL
cells	NULL
from	NULL
patients	NULL
with	NULL
chronic	NULL
myelocytic	NULL
leukaemia	NULL
in	NULL
blastic	NULL
crisis	NULL
predicts	NULL
a	NULL
high	NULL
response	NULL
rate	NULL
to	NULL
chemotherapy	NULL
.	NULL

The	NULL
state	NULL
of	NULL
two	NULL
other	NULL
enzymes	NULL
,	NULL
5'nucleotidase	NULL
and	NULL
adenosine	NULL
deaminase	NULL
,	NULL
is	NULL
less	NULL
certain	NULL
.	NULL

Activity	NULL
of	NULL
5'nucleotidase	NULL
appears	NULL
to	NULL
be	NULL
lower	NULL
in	NULL
mature	NULL
than	NULL
immature	NULL
lymphocytes	NULL
;	NULL
and	NULL
it	NULL
is	NULL
considerably	NULL
decreased	NULL
in	NULL
chronic	NULL
lymphocytic	NULL
leukaemia	NULL
,	NULL
suggesting	NULL
its	NULL
usefulness	NULL
as	NULL
a	NULL
marker	NULL
for	NULL
cellular	NULL
differentiation	NULL
.	NULL

So	NULL
far	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
activity	NULL
of	NULL
5'nucleotidase	NULL
in	NULL
acute	NULL
non-lymphocytic	NULL
leukaemia	NULL
.	NULL
``	NULL

Adenosine	NULL
deaminase	NULL
was	NULL
initially	NULL
suggested	NULL
as	NULL
a	NULL
marker	NULL
for	NULL
blast	NULL
cells	NULL
in	NULL
acute	NULL
lymphocytic	NULL
leukaemia	NULL
,	NULL
but	NULL
some	NULL
patients	NULL
with	NULL
acute	NULL
non-lymphocytic	NULL
leukaemia	NULL
also	NULL
show	NULL
high	NULL
activity	NULL
of	NULL
the	NULL
enzyme	NULL
.	NULL
``	NULL

We	NULL
do	NULL
not	NULL
know	NULL
whether	NULL
measurements	NULL
of	NULL
adenosine	NULL
deaminase	NULL
activity	NULL
might	NULL
be	NULL
useful	NULL
in	NULL
defining	NULL
new	NULL
subgroups	NULL
in	NULL
acute	NULL
non-lymphocytic	NULL
leukaemia	NULL
.	NULL

Determinations	NULL
of	NULL
glucocorticoid	NULL
receptor	NULL
concentrations	NULL
in	NULL
lymphoblasts	NULL
from	NULL
children	NULL
with	NULL
acute	NULL
lymphocytic	NULL
leukaemia	NULL
have	NULL
shown	NULL
a	NULL
correlation	NULL
between	NULL
high	NULL
receptor	NULL
concentrations	NULL
and	NULL
response	NULL
to	NULL
cytostatic	NULL
drug	NULL
combinations	NULL
containing	NULL
glucocorticoids	NULL
.	NULL
``	NULL

Little	NULL
is	NULL
known	NULL
about	NULL
glucocorticoid	NULL
receptors	NULL
in	NULL
acute	NULL
non-lymphocytic	NULL
leukaemia	NULL
.	NULL

We	NULL
undertook	NULL
the	NULL
present	NULL
study	NULL
to	NULL
evaluate	NULL
TdT	NULL
,	NULL
adenosine	NULL
deaminase	NULL
,	NULL
and	NULL
5'nucleotidase	NULL
activities	NULL
and	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
concentration	NULL
as	NULL
indicators	NULL
of	NULL
prognosis	NULL
in	NULL
acute	NULL
non-lymphocytic	NULL
leukaemia	NULL
.	NULL

Patients	NULL
We	NULL
studied	NULL
25	NULL
adults	NULL
with	NULL
untreated	NULL
acute	NULL
non-lymphocytic	NULL
leukaemia	NULL
included	NULL
in	NULL
the	NULL
protocol	NULL
of	NULL
the	NULL
Swedish	NULL
Leukaemia	NULL
Study	NULL
Group	NULL
.	NULL

The	NULL
age	NULL
range	NULL
was	NULL
19-86	NULL
years	NULL
(	NULL
median	NULL
age	NULL
57	NULL
years	NULL
)	NULL
.	NULL

There	NULL
were	NULL
13	NULL
women	NULL
and	NULL
12	NULL
men	NULL
.	NULL

Fifteen	NULL
patients	NULL
were	NULL
aged	NULL
under	NULL
60	NULL
years	NULL
and	NULL
were	NULL
treated	NULL
with	NULL
daunorubicin	NULL
plus	NULL
cytarabine	NULL
initially	NULL
and	NULL
after	NULL
remission	NULL
with	NULL
either	NULL
daunorubicin	NULL
plus	NULL
cytarabine	NULL
or	NULL
cytarabine	NULL
plus	NULL
thioguanine	NULL
.	NULL

The	NULL
10	NULL
patients	NULL
aged	NULL
60	NULL
years	NULL
and	NULL
over	NULL
received	NULL
a	NULL
milder	NULL
initial	NULL
treatment	NULL
:	NULL
thioguanine	NULL
plus	NULL
cytarabine	NULL
in	NULL
eight	NULL
and	NULL
prednimustine	NULL
(	NULL
Leo	NULL
,	NULL
Sweden	NULL
)	NULL
in	NULL
two	NULL
.	NULL

The	NULL
overall	NULL
remission	NULL
rate	NULL
was	NULL
40	NULL
%	NULL
.	NULL

Acute	NULL
non-lymphocytic	NULL
leukaemia	NULL
was	NULL
diagnosed	NULL
primarily	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
routinely	NULL
stained	NULL
slides	NULL
(	NULL
May-Griinwald-Giemsa	NULL
)	NULL
and	NULL
on	NULL
standard	NULL
morphological	NULL
criteria	NULL
.	NULL

In	NULL
some	NULL
cases	NULL
cytochemical	NULL
stainings	NULL
were	NULL
made	NULL
primarily	NULL
.	NULL

All	NULL
slides	NULL
were	NULL
reviewed	NULL
by	NULL
one	NULL
of	NULL
us	NULL
(	NULL
A0	NULL
)	NULL
,	NULL
and	NULL
cytochemical	NULL
characterisation	NULL
was	NULL
performed	NULL
on	NULL
thawed	NULL
specimens	NULL
according	NULL
to	NULL
the	NULL
technique	NULL
of	NULL
Ogier	NULL
et	NULL
al	NULL
(	NULL
paper	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

The	NULL
staining	NULL
methods	NULL
used	NULL
were	NULL
peroxidase	NULL
,	NULL
°	NULL
naphthol	NULL
AS-D	NULL
acetate	NULL
esterase	NULL
with	NULL
and	NULL
without	NULL
sodium	NULL
fluoride	NULL
,	NULL
°	NULL
``	NULL
``	NULL
and	NULL
naphthol	NULL
AS-D	NULL
chloroacetate	NULL
esterase	NULL
.	NULL
``	NULL

The	NULL
classification	NULL
was	NULL
made	NULL
according	NULL
to	NULL
the	NULL
FAB	NULL
classification	NULL
.	NULL
'	NULL

''	NULL
Sixteen	NULL
patients	NULL
were	NULL
classified	NULL
as	NULL
having	NULL
myeloblastic	NULL
leukaemias	NULL
(	NULL
MI-M2	NULL
)	NULL
and	NULL
eight	NULL
as	NULL
having	NULL
acute	NULL
myelo-	NULL
BRITISH	NULL
MEDICAL	NULL
JOURNAL	NULL
-	NULL
VOLUME	NULL
282	NULL
6	NULL
junE	NULL
1981	NULL
Clinical	NULL
and	NULL
haematological	NULL
data	NULL
on	NULL
patients	NULL
studied	NULL
1827	NULL
Peripheral	NULL
blood	NULL
Bone	NULL
marrow	NULL
Diagnosis	NULL
Duration	NULL
of	NULL
Case	NULL
Age	NULL
-	NULL
Sex	NULL
White	NULL
Enzyme	NULL
activities	NULL
(	NULL
units/ug	NULL
DNA	NULL
)	NULL
FAB	NULL
Remission	NULL
remission	NULL
No	NULL
(	NULL
years	NULL
)	NULL
cell	NULL
Blast	NULL
Dexamethasone	NULL
Blast	NULL
Auer	NULL
classification	NULL
)	NULL
(	NULL
days	NULL
)	NULL
count	NULL
cells	NULL
Adenosine	NULL
receptor	NULL
cells	NULL
rods	NULL
(	NULL
x	NULL
10/1	NULL
)	NULL
(	NULL
``	NULL
w	NULL
)	NULL
TIT	NULL
deaminase	NULL
5'Nucleotidase	NULL
(	NULL
fmol/ug	NULL
DNA	NULL
)	NULL
%	NULL
o	NULL
1	NULL
42	NULL
F	NULL
7	NULL
62	NULL
3-10	NULL
128	NULL
0-03	NULL
0-43	NULL
79	NULL
-	NULL
M1	NULL
Yes	NULL
2880*	NULL
2	NULL
36	NULL
M	NULL
41	NULL
88	NULL
0-58	NULL
20-0	NULL
0-68	NULL
0-29	NULL
82	NULL
+	NULL
M2	NULL
Yes	NULL
384*	NULL
3	NULL
45	NULL
F	NULL
38	NULL
74	NULL
0-01	NULL
712	NULL
0-47	NULL
0-52	NULL
67	NULL
+	NULL
M2	NULL
Yes	NULL
146*	NULL
4	NULL
19	NULL
M	NULL
19	NULL
52	NULL
1-24	NULL
444	NULL
0-32	NULL
0-22	NULL
56	NULL
+	NULL
M2	NULL
No	NULL
60+	NULL
5	NULL
33	NULL
F	NULL
33	NULL
93	NULL
0-01	NULL
29-4	NULL
0-27	NULL
0-38	NULL
82	NULL
+	NULL
M2	NULL
Yes	NULL
188*	NULL
6	NULL
27	NULL
M	NULL
21	NULL
90	NULL
0-42	NULL
39-1	NULL
0-32	NULL
0-68	NULL
85	NULL
+	NULL
M2	NULL
Yes	NULL
236*	NULL
7	NULL
54	NULL
F	NULL
30	NULL
68	NULL
0-01	NULL
14-0	NULL
0-16	NULL
0-14	NULL
89	NULL
-	NULL
M2	NULL
No	NULL
36	NULL
8	NULL
67	NULL
F	NULL
273	NULL
96	NULL
0-01	NULL
ND	NULL
0-75	NULL
0-12	NULL
91	NULL
-	NULL
M1	NULL
No	NULL
14	NULL
9	NULL
57	NULL
M	NULL
42	NULL
92	NULL
0-01	NULL
188	NULL
0-68	NULL
0-18	NULL
ND	NULL
+	NULL
M1	NULL
No	NULL
29	NULL
10	NULL
43	NULL
M	NULL
17	NULL
30	NULL
0-90	NULL
0-4	NULL
0-24	NULL
0-18	NULL
56	NULL
+	NULL
MSb	NULL
Yes	NULL
543*	NULL
11	NULL
86	NULL
F	NULL
164	NULL
95	NULL
0-01	NULL
155	NULL
ND	NULL
0-16	NULL
94	NULL
+	NULL
M1	NULL
No	NULL
12	NULL
61	NULL
F	NULL
204	NULL
97	NULL
19-20	NULL
15-5	NULL
4:31	NULL
0-94	NULL
97	NULL
-	NULL
AUL	NULL
?	NULL

Yes	NULL
201	NULL
13	NULL
23	NULL
M	NULL
36	NULL
84	NULL
0-01	NULL
ND	NULL
ND	NULL
0-20	NULL
79	NULL
-	NULL
M5b	NULL
No	NULL
14	NULL
81	NULL
F	NULL
120	NULL
85	NULL
0-78	NULL
ND	NULL
0-50	NULL
0-80	NULL
94	NULL
-	NULL
M1	NULL
No	NULL
2	NULL
15	NULL
59	NULL
M	NULL
116	NULL
76	NULL
0-09	NULL
ND	NULL
0-62	NULL
0-15	NULL
56	NULL
-	NULL
M4	NULL
No	NULL
51	NULL
16	NULL
21	NULL
M	NULL
39	NULL
63	NULL
0-67	NULL
25-8	NULL
2:93	NULL
0-52	NULL
55	NULL
+	NULL
M4	NULL
Yes	NULL
478*	NULL
17	NULL
70	NULL
F	NULL
38	NULL
22	NULL
0-01	NULL
1-0	NULL
0-13	NULL
0-14	NULL
37	NULL
+	NULL
M4	NULL
No	NULL
37	NULL
18	NULL
78	NULL
M	NULL
27	NULL
79	NULL
0-01	NULL
164	NULL
0-08	NULL
0-47	NULL
89	NULL
+	NULL
M1	NULL
No	NULL
19	NULL
59	NULL
M	NULL
101	NULL
66	NULL
0-01	NULL
34-8	NULL
0-49	NULL
0-43	NULL
62	NULL
-	NULL
M4	NULL
Yes	NULL
110*	NULL
20	NULL
47	NULL
F	NULL
80	NULL
71	NULL
0-01	NULL
17-2	NULL
0-70	NULL
0-14	NULL
60	NULL
+	NULL
M2	NULL
No	NULL
115	NULL
21	NULL
60	NULL
M	NULL
6	NULL
29	NULL
0-01	NULL
1119	NULL
0-35	NULL
0-22	NULL
25	NULL
-	NULL
MSb	NULL
No	NULL
147	NULL
22	NULL
48	NULL
F	NULL
128	NULL
74	NULL
0-01	NULL
27-4	NULL
116	NULL
0	NULL
63	NULL
+	NULL
M2	NULL
No	NULL
12	NULL
23	NULL
83	NULL
F	NULL
150	NULL
90	NULL
257	NULL
8-2	NULL
0-10	NULL
0-14	NULL
87	NULL
-	NULL
M2	NULL
No	NULL
7	NULL
24	NULL
81	NULL
F	NULL
5	NULL
66	NULL
0-99	NULL
12	NULL
0-09	NULL
0-21	NULL
86	NULL
-	NULL
M1	NULL
No	NULL
0	NULL
25	NULL
71	NULL
M	NULL
29	NULL
26	NULL
1+24	NULL
7-4	NULL
0-46	NULL
0-29	NULL
40	NULL
-	NULL
MSb	NULL
Yes	NULL
213*	NULL
TdT	NULL
=	NULL
Terminal	NULL
deoxynucleotidyl	NULL
transferase	NULL
.	NULL

ND	NULL
=	NULL
Not	NULL
done	NULL
.	NULL

AUL	NULL
=	NULL
Acute	NULL
undifferentiated	NULL
leukaemia	NULL
.	NULL

*Alive	NULL
on	NULL
1	NULL
October	NULL
1979.	NULL
monocytic	NULL
or	NULL
acute	NULL
monocytic	NULL
type	NULL
(	NULL
M4-M5	NULL
)	NULL
.	NULL

Only	NULL
one	NULL
patient	NULL
(	NULL
case	NULL
12	NULL
)	NULL
had	NULL
a	NULL
negative	NULL
cytochemical	NULL
profile	NULL
and	NULL
no	NULL
detectable	NULL
Auer	NULL
rods	NULL
,	NULL
suggesting	NULL
an	NULL
acute	NULL
undifferentiated	NULL
or	NULL
an	NULL
acute	NULL
lymphocytic	NULL
leukaemia	NULL
.	NULL

This	NULL
patient	NULL
was	NULL
primarily	NULL
diagnosed	NULL
as	NULL
having	NULL
acute	NULL
myeloblastic	NULL
leukaemia	NULL
and	NULL
was	NULL
therefore	NULL
treated	NULL
according	NULL
to	NULL
the	NULL
common	NULL
protocol	NULL
for	NULL
acute	NULL
non-lymphocytic	NULL
leukaemia	NULL
.	NULL

The	NULL
table	NULL
gives	NULL
clinical	NULL
and	NULL
haematological	NULL
data	NULL
on	NULL
each	NULL
patient	NULL
.	NULL

Material	NULL
and	NULL
methods	NULL
Isolation	NULL
of	NULL
blast	NULL
cells-Peripheral	NULL
blood	NULL
from	NULL
patients	NULL
with	NULL
untreated	NULL
leukaemia	NULL
was	NULL
collected	NULL
into	NULL
heparinised	NULL
tubes	NULL
;	NULL
the	NULL
buffy	NULL
coat	NULL
was	NULL
isolated	NULL
after	NULL
spontaneous	NULL
sedimentation	NULL
and	NULL
cryopreserved	NULL
in	NULL
liquid	NULL
nitrogen	NULL
.	NULL

Blast	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
the	NULL
thawed	NULL
buffy	NULL
coat	NULL
by	NULL
Ficoll-Isopaque	NULL
density-gradient	NULL
centrifugation	NULL
.	NULL

They	NULL
were	NULL
washed	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
after	NULL
which	NULL
their	NULL
viability	NULL
was	NULL
tested	NULL
by	NULL
the	NULL
trypan	NULL
blue	NULL
dye	NULL
exlusion	NULL
test	NULL
.	NULL

In	NULL
no	NULL
case	NULL
was	NULL
the	NULL
viability	NULL
less	NULL
than	NULL
95	NULL
%	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
sedimented	NULL
and	NULL
either	NULL
used	NULL
immediately	NULL
for	NULL
biochemical	NULL
analysis	NULL
or	NULL
frozen	NULL
as	NULL
a	NULL
pellet	NULL
and	NULL
stored	NULL
in	NULL
liquid	NULL
nitrogen	NULL
until	NULL
used	NULL
.	NULL

Glucocorticoid	NULL
receptor	NULL
concentrations-Cells	NULL
were	NULL
thawed	NULL
on	NULL
ice	NULL
,	NULL
and	NULL
0-5	NULL
ml	NULL
of	NULL
TE	NULL
buffer	NULL
(	NULL
TRIS	NULL
hydrochloric	NULL
acid	NULL
10	NULL
mmol/l	NULL
(	NULL
pH	NULL
7-2	NULL
)	NULL
,	NULL
EDTA	NULL
1-5	NULL
mmol/l	NULL
)	NULL
containing	NULL
dithiotreitol	NULL
1	NULL
mmol/l	NULL
and	NULL
*H-dexa-methasone	NULL
(	NULL
25	NULL
Ci/mmol	NULL
,	NULL
Radiochemical	NULL
Centre	NULL
,	NULL
Amersham	NULL
)	NULL
500	NULL
nmol/l	NULL
was	NULL
added	NULL
.	NULL

The	NULL
tissue	NULL
was	NULL
homogenised	NULL
with	NULL
a	NULL
Polytrone	NULL
(	NULL
2	NULL
x	NULL
15	NULL
s	NULL
,	NULL
setting	NULL
3	NULL
)	NULL
and	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
60	NULL
minutes	NULL
.	NULL

The	NULL
homogenate	NULL
was	NULL
centrifuged	NULL
at	NULL
20	NULL
000	NULL
g	NULL
for	NULL
20	NULL
minutes	NULL
and	NULL
an	NULL
aliquot	NULL
of	NULL
the	NULL
supernatant	NULL
solution	NULL
removed	NULL
for	NULL
determination	NULL
of	NULL
protein	NULL
content	NULL
by	NULL
measuring	NULL
the	NULL
difference	NULL
in	NULL
absorbance	NULL
at	NULL
280	NULL
and	NULL
310	NULL
nm	NULL
.	NULL

The	NULL
pellet	NULL
was	NULL
analysed	NULL
for	NULL
DNA	NULL
content	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Burton	NULL
,	NULL
!	NULL
``	NULL

which	NULL
was	NULL
used	NULL
as	NULL
the	NULL
reference	NULL
measurement	NULL
of	NULL
specific	NULL
binding	NULL
.	NULL

Crystallised	NULL
trypsin	NULL
(	NULL
Worthington	NULL
)	NULL
was	NULL
added	NULL
(	NULL
5	NULL
ug/optical	NULL
density	NULL
unit	NULL
of	NULL
cytosol	NULL
)	NULL
,	NULL
and	NULL
after	NULL
incubation	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
10°C	NULL
the	NULL
cytosol	NULL
was	NULL
shaken	NULL
with	NULL
one-fifth	NULL
volume	NULL
of	NULL
dextran-coated	NULL
charcoal	NULL
(	NULL
dextran	NULL
:	NULL
charcoal=1:10	NULL
w/w	NULL
)	NULL
.	NULL

The	NULL
suspension	NULL
was	NULL
centrifuged	NULL
at	NULL
800	NULL
g	NULL
for	NULL
10	NULL
minutes	NULL
and	NULL
the	NULL
resulting	NULL
supernatant	NULL
placed	NULL
in	NULL
300	NULL
ul	NULL
sample	NULL
frames	NULL
on	NULL
polyacrylamide	NULL
gels	NULL
(	NULL
LKB	NULL
,	NULL
pH	NULL
range	NULL
3-5-10-0	NULL
)	NULL
near	NULL
the	NULL
cathode	NULL
at	NULL
approximately	NULL
pH	NULL
8	NULL
and	NULL
subjected	NULL
to	NULL
isoelectric	NULL
focusing	NULL
for	NULL
two	NULL
hours	NULL
(	NULL
Ogier	NULL
et	NULL
al	NULL
,	NULL
paper	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

After	NULL
pH	NULL
measurement	NULL
the	NULL
gel	NULL
was	NULL
cut	NULL
into	NULL
5	NULL
mm	NULL
slices	NULL
and	NULL
placed	NULL
in	NULL
5	NULL
ml	NULL
Instagel	NULL
(	NULL
Packard	NULL
)	NULL
.	NULL

After	NULL
incubation	NULL
overnight	NULL
at	NULL
20°C	NULL
the	NULL
radioactivity	NULL
was	NULL
measured	NULL
in	NULL
a	NULL
Packard	NULL
liquid	NULL
scintillation	NULL
counter	NULL
.	NULL

The	NULL
radioactivity	NULL
moving	NULL
as	NULL
a	NULL
single	NULL
peak	NULL
in	NULL
the	NULL
pH	NULL
6	NULL
region	NULL
was	NULL
taken	NULL
as	NULL
a	NULL
measure	NULL
of	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
.	NULL

Excess	NULL
of	NULL
unlabelled	NULL
dexamethasone	NULL
in	NULL
the	NULL
incubation	NULL
mixture	NULL
resulted	NULL
in	NULL
elimination	NULL
of	NULL
90-100	NULL
%	NULL
of	NULL
this	NULL
peak	NULL
.	NULL

Enzyme	NULL
analysis-TdT	NULL
(	NULL
Enzyme	NULL
Commission	NULL
2	NULL
7	NULL
7	NULL
31	NULL
)	NULL
was	NULL
assayed	NULL
by	NULL
the	NULL
following	NULL
method	NULL
.	NULL

Pellets	NULL
of	NULL
leukaemic	NULL
cells	NULL
were	NULL
thawed	NULL
in	NULL
ice-cold	NULL
potassium	NULL
phosphate	NULL
buffer	NULL
(	NULL
0-25	NULL
mol/l	NULL
;	NULL
pH	NULL
7-5	NULL
)	NULL
and	NULL
homogenised	NULL
in	NULL
a	NULL
Polytron	NULL
homogeniser	NULL
(	NULL
2	NULL
x	NULL
15	NULL
s	NULL
,	NULL
setting	NULL
3	NULL
)	NULL
.	NULL

The	NULL
homogenate	NULL
was	NULL
stirred	NULL
for	NULL
one	NULL
hour	NULL
at	NULL
4°C	NULL
.	NULL

A	NULL
fraction	NULL
of	NULL
this	NULL
solution	NULL
was	NULL
precipitated	NULL
with	NULL
perchloric	NULL
acid	NULL
0-5	NULL
mol/l	NULL
and	NULL
the	NULL
resulting	NULL
pellet	NULL
used	NULL
for	NULL
DNA	NULL
determination	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Burton	NULL
.	NULL
``	NULL

The	NULL
remaining	NULL
homogenate	NULL
was	NULL
centrifuged	NULL
at	NULL
100	NULL
000	NULL
g	NULL
for	NULL
one	NULL
hour	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
used	NULL
for	NULL
determination	NULL
of	NULL
TdT	NULL
activity	NULL
.	NULL

The	NULL
assay	NULL
mixture	NULL
contained	NULL
in	NULL
a	NULL
volume	NULL
of	NULL
0-1	NULL
ml	NULL
:	NULL
0-025	NULL
optical	NULL
density	NULL
units	NULL
of	NULL
poly	NULL
p-adenosine	NULL
;	NULL
;	NULL
-i	NULL
&	NULL
,	NULL
(	NULL
P	NULL
L	NULL
Bioch	NULL
Co	NULL
,	NULL
Milwaukee	NULL
,	NULL
USA	NULL
)	NULL
;	NULL
0-1	NULL
umol	NULL
*H-D-guanosine	NULL
triphosphate	NULL
(	NULL
specific	NULL
activity	NULL
3000	NULL
cpm/pmol	NULL
;	NULL
Radiochemical	NULL
Centre	NULL
,	NULL
Amersham	NULL
)	NULL
;	NULL
TRIS	NULL
hydrochloric	NULL
acid	NULL
42	NULL
mmol/l	NULL
(	NULL
pH	NULL
7-5	NULL
)	NULL
;	NULL
potassium	NULL
chloride	NULL
42	NULL
mmol/l	NULL
;	NULL
dithiothreitol	NULL
42	NULL
mmol/l	NULL
;	NULL
manganese	NULL
chloride	NULL
80	NULL
umol/l	NULL
;	NULL
and	NULL
5-25	NULL
pl	NULL
of	NULL
the	NULL
supernatant	NULL
as	NULL
the	NULL
enzyme	NULL
source	NULL
.	NULL

After	NULL
30	NULL
minutes	NULL
at	NULL
37°C	NULL
the	NULL
tubes	NULL
were	NULL
transferred	NULL
into	NULL
ice	NULL
,	NULL
and	NULL
0-2	NULL
ml	NULL
of	NULL
10	NULL
%	NULL
trichloroacetic	NULL
acid	NULL
containing	NULL
sodium	NULL
pyrophosphate	NULL
0-02	NULL
mol/l	NULL
was	NULL
added	NULL
.	NULL

The	NULL
mixture	NULL
was	NULL
left	NULL
on	NULL
ice	NULL
for	NULL
30	NULL
minutes	NULL
.	NULL

The	NULL
acid-insoluble	NULL
fraction	NULL
was	NULL
collected	NULL
on	NULL
a	NULL
glass-fibre	NULL
filter	NULL
(	NULL
Whatman	NULL
GF-C	NULL
)	NULL
,	NULL
which	NULL
was	NULL
washed	NULL
with	NULL
10	NULL
ml	NULL
of	NULL
ice-cold	NULL
10	NULL
%	NULL
trichloroacetic	NULL
acid	NULL
containing	NULL
sodium	NULL
pyrophosphate	NULL
0-02	NULL
mol/l	NULL
.	NULL

After	NULL
drying	NULL
,	NULL
the	NULL
radioactivity	NULL
of	NULL
the	NULL
filters	NULL
was	NULL
measured	NULL
in	NULL
a	NULL
liquid	NULL
scintillation	NULL
counter	NULL
.	NULL

Activity	NULL
of	NULL
5'nucleotidase	NULL
(	NULL
Enzyme	NULL
Commission	NULL
3	NULL
1	NULL
3	NULL
5	NULL
)	NULL
was	NULL
measured	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Quagilata	NULL
et	NULL
al.s	NULL
Adenosine	NULL
deaminase	NULL
(	NULL
Enzyme	NULL
Commission	NULL
3	NULL
5	NULL
4	NULL
4	NULL
)	NULL
activities	NULL
were	NULL
measured®	NULL
in	NULL
extracts	NULL
used	NULL
also	NULL
for	NULL
TdT	NULL
determinations	NULL
.	NULL

Results	NULL
Glucocorticoid	NULL
receptor	NULL
concentrations	NULL
in	NULL
blasts-Twenty-four	NULL
patients	NULL
had	NULL
dexamethasone	NULL
values	NULL
of	NULL
between	NULL
0-12	NULL
and	NULL
0-94	NULL
fmol/ug	NULL
DNA	NULL
.	NULL

In	NULL
one	NULL
patient	NULL
we	NULL
were	NULL
unable	NULL
to	NULL
detect	NULL
receptor	NULL
(	NULL
table	NULL
)	NULL
.	NULL

The	NULL
median	NULL
value	NULL
was	NULL
0-22	NULL
fmol/ug	NULL
DNA	NULL
,	NULL
corresponding	NULL
to	NULL
approximately	NULL
1300	NULL
receptor	NULL
mol/cell	NULL
.	NULL

Figure	NULL
1	NULL
compares	NULL
the	NULL
survival	NULL
of	NULL
the	NULL
12	NULL
patients	NULL
with	NULL
receptor	NULL
concentrations	NULL
below	NULL
0-22	NULL
fmol/ug	NULL
DNA	NULL
with	NULL
that	NULL
of	NULL
the	NULL
13	NULL
patients	NULL
with	NULL
a	NULL
cellular	NULL
receptor	NULL
concentration	NULL
of	NULL
022-094	NULL
fmol/ug	NULL
DNA	NULL
.	NULL

Clearly	NULL
,	NULL
increased	NULL
receptor	NULL
concentrations	NULL
were	NULL
correlated	NULL
with	NULL
increased	NULL
survival	NULL
(	NULL
p=0-006	NULL
,	NULL
log-rank	NULL
test	NULL
)	NULL
.	NULL

We	NULL
also	NULL
analysed	NULL
separately	NULL
the	NULL
14	NULL
patients	NULL
aged	NULL
under	NULL
60	NULL
.	NULL

The	NULL
decreased	NULL
survival	NULL
among	NULL
those	NULL
with	NULL
less	NULL
than	NULL
the	NULL
median	NULL
amount	NULL
of	NULL
receptor	NULL
was	NULL
also	NULL
evident	NULL
in	NULL
this	NULL
group	NULL
and	NULL
was	NULL
significant	NULL
(	NULL
p=0-011	NULL
,	NULL
log-rank	NULL
test	NULL
)	NULL
.	NULL

TdT	NULL
activity-The	NULL
table	NULL
shows	NULL
that	NULL
11	NULL
of	NULL
the	NULL
patients	NULL
had	NULL
TIT	NULL
activities	NULL
of	NULL
0-4-19-2	NULL
units/ug	NULL
DNA	NULL
while	NULL
14	NULL
patients	NULL
had	NULL
low	NULL
activities	NULL
(	NULL
undetectable	NULL
to	NULL
0-09	NULL
units/ug	NULL
DNA	NULL
)	NULL
.	NULL

Figure	NULL
2	NULL
compares	NULL
the	NULL
survival	NULL
of	NULL
the	NULL
11	NULL
patients	NULL
with	NULL
high	NULL
(	NULL
>	NULL
0-1	NULL
units/ug	NULL
DNA	NULL
)	NULL
TdT	NULL
activity	NULL
with	NULL
the	NULL
survival	NULL
of	NULL
the	NULL
14	NULL
patients	NULL
with	NULL
low	NULL
(	NULL
<	NULL
0-1	NULL
units/ug	NULL
DNA	NULL
)	NULL
TdT	NULL
activity	NULL
.	NULL

Survival	NULL
appeared	NULL
to	NULL
be	NULL
increased	NULL
in	NULL
the	NULL
11	NULL
patients	NULL
with	NULL
increased	NULL
activity	NULL
(	NULL
p=0-06	NULL
,	NULL
log-rank	NULL
test	NULL
)	NULL
.	NULL

The	NULL
survival	NULL
of	NULL
the	NULL
six	NULL
young	NULL
patients	NULL
with	NULL
TdT	NULL
activity	NULL
over	NULL
0-1	NULL
units/ug	NULL
DNA	NULL
was	NULL
com	NULL
1828	NULL
pared	NULL
separately	NULL
with	NULL
that	NULL
of	NULL
the	NULL
nine	NULL
young	NULL
patients	NULL
with	NULL
low	NULL
TdT	NULL
activity	NULL
.	NULL

Figure	NULL
3	NULL
shows	NULL
a	NULL
significantly	NULL
increased	NULL
survival	NULL
(	NULL
p=0-035	NULL
,	NULL
log-rank	NULL
test	NULL
)	NULL
in	NULL
the	NULL
young	NULL
patients	NULL
with	NULL
high	NULL
TdT	NULL
activity	NULL
.	NULL

100	NULL
50	NULL
Survival	NULL
(	NULL
%	NULL
)	NULL
0	NULL
0	NULL
-	NULL
100	NULL
200	NULL
Days	NULL
FIG	NULL
1-Survival	NULL
of	NULL
13	NULL
patients	NULL
with	NULL
>	NULL
0-22	NULL
fmol	NULL
glucocorticoid	NULL
receptor/ug	NULL
DNA	NULL
(	NULL
-	NULL
-	NULL
-	NULL
-	NULL
)	NULL
and	NULL
12	NULL
patients	NULL
with	NULL
<	NULL
0-22	NULL
fmol	NULL
receptor/ug	NULL
DNA	NULL
(	NULL
)	NULL
.	NULL

3	NULL
>	NULL
cm	NULL
sas	NULL
ap	NULL
muses	NULL
age	NULL
es	NULL
ss	NULL
sp	NULL
3	NULL
&	NULL
0	NULL
4r	NULL
v	NULL
r	NULL
v	NULL
v	NULL
0	NULL
100	NULL
200	NULL
300	NULL
400	NULL
500	NULL
i	NULL
Days	NULL
FIG	NULL
2-Survival	NULL
of	NULL
11	NULL
patients	NULL
with	NULL
high	NULL
TdT	NULL
activity	NULL
(	NULL
-	NULL
--	NULL
-	NULL
)	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
14	NULL
patients	NULL
with	NULL
low	NULL
TdT	NULL
activity	NULL
(	NULL
.	NULL

Survival	NULL
(	NULL
%	NULL
)	NULL
0	NULL
v	NULL
v	NULL
v	NULL
v	NULL
0	NULL
100	NULL
200	NULL
300	NULL
400	NULL
500	NULL
Days	NULL
FIG	NULL
3-Survival	NULL
of	NULL
six	NULL
young	NULL
patients	NULL
(	NULL
aged	NULL
<	NULL
60	NULL
years	NULL
)	NULL
with	NULL
high	NULL
TdT	NULL
activity	NULL
(	NULL
-	NULL
--	NULL
-	NULL
)	NULL
compared	NULL
with	NULL
survival	NULL
of	NULL
nine	NULL
young	NULL
patients	NULL
with	NULL
low	NULL
T	NULL
&	NULL
T	NULL
activity	NULL
(	NULL
--	NULL
)	NULL
.	NULL

Combination	NULL
of	NULL
receptor	NULL
concentration	NULL
and	NULL
TdT	NULL
activity	NULL
as	NULL
predictors	NULL
of	NULL
survival-We	NULL
further	NULL
analysed	NULL
the	NULL
survival	NULL
of	NULL
the	NULL
14	NULL
patients	NULL
with	NULL
low	NULL
TdT	NULL
activity	NULL
in	NULL
their	NULL
blast	NULL
cells	NULL
.	NULL

Figure	NULL
4	NULL
shows	NULL
that	NULL
nine	NULL
patients	NULL
who	NULL
had	NULL
a	NULL
dexamethasone	NULL
concentration	NULL
lower	NULL
than	NULL
0-22	NULL
fmol/ug	NULL
DNA	NULL
showed	NULL
a	NULL
decreased	NULL
survival	NULL
expectancy	NULL
(	NULL
p=0-034	NULL
,	NULL
log-rank	NULL
test	NULL
)	NULL
compared	NULL
with	NULL
those	NULL
with	NULL
a	NULL
dexamethasone	NULL
concentration	NULL
over	NULL
the	NULL
median	NULL
value	NULL
.	NULL

Adenosine	NULL
deaminase	NULL
-	NULL
and	NULL
|	NULL
5'nucleotidase	NULL
-	NULL
activities-Adenosine	NULL
deaminase	NULL
activity	NULL
was	NULL
measured	NULL
in	NULL
blast	NULL
cells	NULL
obtained	NULL
from	NULL
21	NULL
patients	NULL
and	NULL
varied	NULL
from	NULL
0-4	NULL
to	NULL
71-0	NULL
units/ug	NULL
DNA	NULL
(	NULL
table	NULL
)	NULL
.	NULL

The	NULL
BRITISH	NULL
MEDICAL	NULL
JOURNAL	NULL
-	NULL
VOLUME	NULL
282	NULL
6	NULL
jung	NULL
1981	NULL
rec	NULL
``	NULL
:	NULL
--	NULL
-*ri	NULL
_-	NULL
1	NULL
E	NULL
*r~7	NULL
E	NULL
i	NULL
;	NULL
Ie	NULL
mn	NULL
me	NULL
m	NULL
me	NULL
m	NULL
wae	NULL
me	NULL
me	NULL
we	NULL
we	NULL
m	NULL
m	NULL
ge	NULL
me	NULL
n	NULL
m	NULL
me	NULL
ae	NULL
in	NULL
bntabntaich	NULL
I	NULL
3	NULL
)	NULL
05	NULL
r	NULL
r	NULL
r	NULL
v	NULL
r	NULL
0	NULL
100	NULL
200	NULL
300	NULL
400	NULL
500	NULL
Days	NULL
1	NULL
FIG	NULL
4-Survival	NULL
of	NULL
the	NULL
14	NULL
patients	NULL
with	NULL
low	NULL
TdT	NULL
activity	NULL
:	NULL
five	NULL
patients	NULL
had	NULL
glucocorticoid	NULL
receptor	NULL
concentrations	NULL
;	NULL
>	NULL
022	NULL
fmol/iug	NULL
DNA	NULL
(	NULL
--	NULL
)	NULL
and	NULL
nine	NULL
had	NULL
receptor	NULL
concentrations	NULL
<	NULL
0:22	NULL
fmol/ug	NULL
DNA	NULL
(	NULL
-	NULL
--	NULL
-	NULL
)	NULL
.	NULL

activity	NULL
of	NULL
5'nucleotidase	NULL
was	NULL
determined	NULL
in	NULL
blasts	NULL
from	NULL
23	NULL
patients	NULL
and	NULL
varied	NULL
between	NULL
0-03	NULL
and	NULL
4-3	NULL
units/ug	NULL
DNA	NULL
(	NULL
table	NULL
)	NULL
.	NULL

No	NULL
correlation	NULL
could	NULL
be	NULL
found	NULL
between	NULL
survival	NULL
rates	NULL
and	NULL
the	NULL
activity	NULL
of	NULL
either	NULL
adenosine	NULL
deaminase	NULL
or	NULL
5	NULL
``	NULL
nucleotidase	NULL
.	NULL

Discussion	NULL
Lippman	NULL
et	NULL
al'*	NULL
showed	NULL
that	NULL
children	NULL
with	NULL
acute	NULL
lymphocytic	NULL
leukaemia	NULL
have	NULL
a	NULL
more	NULL
favourable	NULL
prognosis	NULL
if	NULL
their	NULL
leukaemic	NULL
cells	NULL
contain	NULL
more	NULL
than	NULL
about	NULL
6000	NULL
glucocorticoid	NULL
receptor	NULL
sites	NULL
per	NULL
cell	NULL
.	NULL

The	NULL
interpretation	NULL
of	NULL
this	NULL
finding	NULL
is	NULL
complicated	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
treatment	NULL
programmes	NULL
for	NULL
acute	NULL
lymphocytic	NULL
leukaemia	NULL
contain	NULL
glucocorticoids	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
effect	NULL
might	NULL
be	NULL
due	NULL
to	NULL
either	NULL
a	NULL
more	NULL
favourable	NULL
response	NULL
to	NULL
glucocorticoids	NULL
or	NULL
a	NULL
more	NULL
benign	NULL
biology	NULL
of	NULL
leukaemias	NULL
with	NULL
increased	NULL
receptor	NULL
content	NULL
or	NULL
to	NULL
a	NULL
combination	NULL
of	NULL
these	NULL
factors	NULL
.	NULL

So	NULL
far	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
state	NULL
of	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
in	NULL
acute	NULL
non-lymphocytic	NULL
leukaemia	NULL
.	NULL

We	NULL
found	NULL
a	NULL
median	NULL
value	NULL
of	NULL
0-22	NULL
fmol	NULL
glucocorticoid	NULL
receptor	NULL
per	NULL
ug	NULL
DNA	NULL
in	NULL
this	NULL
disease	NULL
.	NULL

Assuming	NULL
an	NULL
average	NULL
value	NULL
of	NULL
10	NULL
pg	NULL
DNA	NULL
per	NULL
cell	NULL
this	NULL
corresponds	NULL
to	NULL
about	NULL
1300	NULL
sites	NULL
per	NULL
cell	NULL
.	NULL

It	NULL
is	NULL
tempting	NULL
to	NULL
speculate	NULL
that	NULL
the	NULL
low	NULL
receptor	NULL
concentration	NULL
correlates	NULL
with	NULL
the	NULL
limited	NULL
effect	NULL
of	NULL
glucocorticoids	NULL
in	NULL
acute	NULL
non-lymphocytic	NULL
leukaemia	NULL
.	NULL

We	NULL
found	NULL
a	NULL
decreased	NULL
survival	NULL
in	NULL
patients	NULL
with	NULL
less	NULL
than	NULL
0-22	NULL
fmol	NULL
glucocorticoid	NULL
binding	NULL
per	NULL
ug	NULL
DNA	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
corresponding	NULL
finding	NULL
in	NULL
acute	NULL
lymphocytic	NULL
leukaemia	NULL
this	NULL
difference	NULL
can	NULL
not	NULL
be	NULL
explained	NULL
by	NULL
differences	NULL
in	NULL
response	NULL
to	NULL
glucocorticoid	NULL
treatment	NULL
since	NULL
steroids	NULL
were	NULL
not	NULL
included	NULL
in	NULL
the	NULL
treatment	NULL
of	NULL
our	NULL
patients	NULL
.	NULL

It	NULL
rather	NULL
must	NULL
reflect	NULL
a	NULL
more	NULL
aggressive	NULL
biology	NULL
of	NULL
acute	NULL
non-lymphocytic	NULL
leukaemia	NULL
with	NULL
decreased	NULL
receptor	NULL
concentration	NULL
.	NULL

We	NULL
treat	NULL
patients	NULL
over	NULL
60	NULL
years	NULL
of	NULL
age	NULL
with	NULL
a	NULL
milder	NULL
form	NULL
of	NULL
chemotherapy	NULL
.	NULL

Ten	NULL
such	NULL
patients	NULL
participated	NULL
in	NULL
the	NULL
study	NULL
,	NULL
and	NULL
when	NULL
they	NULL
were	NULL
excluded	NULL
from	NULL
the	NULL
analysis	NULL
the	NULL
difference	NULL
between	NULL
patients	NULL
with	NULL
high	NULL
and	NULL
low	NULL
receptor	NULL
concentrations	NULL
was	NULL
still	NULL
evident	NULL
.	NULL

Therefore	NULL
,	NULL
selection	NULL
of	NULL
elderly	NULL
patients	NULL
or	NULL
patients	NULL
treated	NULL
with	NULL
less	NULL
intensive	NULL
chemotherapy	NULL
does	NULL
not	NULL
explain	NULL
the	NULL
decreased	NULL
survival	NULL
of	NULL
patients	NULL
with	NULL
low	NULL
receptor	NULL
concentrations	NULL
.	NULL

TdT	NULL
was	NULL
identified	NULL
as	NULL
a	NULL
characteristic	NULL
of	NULL
immature	NULL
lympho-cytes	NULL
and	NULL
considerable	NULL
TdT	NULL
activity	NULL
was	NULL
found	NULL
in	NULL
blast	NULL
cells	NULL
from	NULL
patients	NULL
with	NULL
lymphocytic	NULL
leukaemia	NULL
Acute	NULL
lymphocytic	NULL
leukaemia	NULL
with	NULL
high	NULL
activity	NULL
of	NULL
TdT	NULL
(	NULL
T-cell	NULL
leukaemia	NULL
)	NULL
has	NULL
a	NULL
decreased	NULL
remission	NULL
rate	NULL
and	NULL
decreased	NULL
survival	NULL
as	NULL
compared	NULL
with	NULL
lymphocytic	NULL
leukaemias	NULL
with	NULL
low	NULL
TdT	NULL
activity	NULL
.	NULL

In	NULL
non-lymphocytic	NULL
leukaemia	NULL
,	NULL
however	NULL
,	NULL
TdT	NULL
activity	NULL
is	NULL
generally	NULL
low	NULL
,	NULL
although	NULL
some	NULL
rare	NULL
cases	NULL
with	NULL
high	NULL
activity	NULL
have	NULL
been	NULL
reported	NULL
.	NULL

Thus	NULL
the	NULL
value	NULL
of	NULL
routine	NULL
measurements	NULL
of	NULL
TdT	NULL
activity	NULL
in	NULL
non-lymphocytic	NULL
leukaemia	NULL
may	NULL
be	NULL
questioned	NULL
.	NULL

There	NULL
is	NULL
evidence	NULL
,	NULL
however	NULL
,	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
TdT	NULL
activity	NULL
in	NULL
chronic	NULL
myelogenous	NULL
leukaemia	NULL
in	NULL
blast	NULL
crises	NULL
confers	NULL
a	NULL
favourable	NULL
prognosis	NULL
of	NULL
response	NULL
to	NULL
chemotherapy	NULL
.	NULL

*	NULL
This	NULL
observation	NULL
BRITISH	NULL
MEDICAL	NULL
JOURNAL	NULL
-	NULL
VOLUME	NULL
282	NULL
6	NULL
jung	NULL
1981	NULL
should	NULL
be	NULL
correlated	NULL
with	NULL
our	NULL
finding	NULL
that	NULL
TdT	NULL
activity	NULL
is	NULL
also	NULL
associated	NULL
with	NULL
increased	NULL
survival	NULL
and	NULL
remission	NULL
rates	NULL
in	NULL
acute	NULL
non-lymphocytic	NULL
leukaemia	NULL
.	NULL

We	NULL
should	NULL
emphasise	NULL
that	NULL
the	NULL
TdT	NULL
activity	NULL
in	NULL
our	NULL
patients	NULL
was	NULL
low	NULL
,	NULL
which	NULL
indirectly	NULL
rules	NULL
out	NULL
that	NULL
some	NULL
with	NULL
acute	NULL
lymphocytic	NULL
leukaemia	NULL
had	NULL
been	NULL
misdiagnosed	NULL
as	NULL
having	NULL
acute	NULL
non-lymphocytic	NULL
leukaemia	NULL
.	NULL

This	NULL
is	NULL
also	NULL
supported	NULL
by	NULL
cytochemical	NULL
and	NULL
morphological	NULL
analysis	NULL
.	NULL

The	NULL
possibility	NULL
still	NULL
exists	NULL
,	NULL
however	NULL
,	NULL
that	NULL
increased	NULL
TdT	NULL
activity	NULL
indicates	NULL
the	NULL
presence	NULL
of	NULL
two	NULL
blast	NULL
populations	NULL
,	NULL
one	NULL
lymphoid	NULL
TdT	NULL
-positive	NULL
and	NULL
a	NULL
second	NULL
myeloid	NULL
or	NULL
monocytic	NULL
TdT	NULL
-negative	NULL
,	NULL
as	NULL
has	NULL
been	NULL
described	NULL
by	NULL
Mertelsmann	NULL
et	NULL
al	NULL
.	NULL
``	NULL

''	NULL
We	NULL
thus	NULL
conclude	NULL
that	NULL
measurements	NULL
of	NULL
glucocorticoid	NULL
receptor	NULL
concentrations	NULL
and	NULL
TdT	NULL
activity	NULL
contribute	NULL
partially	NULL
independent	NULL
prognostic	NULL
information	NULL
.	NULL

When	NULL
both	NULL
are	NULL
decreased	NULL
a	NULL
group	NULL
of	NULL
patients	NULL
with	NULL
a	NULL
much	NULL
decreased	NULL
survival	NULL
is	NULL
identified	NULL
.	NULL

In	NULL
view	NULL
of	NULL
our	NULL
findings	NULL
we	NULL
think	NULL
that	NULL
measurement	NULL
of	NULL
glucocorticoid	NULL
receptor	NULL
concentration	NULL
and	NULL
TdT	NULL
activity	NULL
should	NULL
be	NULL
considered	NULL
in	NULL
the	NULL
design	NULL
of	NULL
future	NULL
prospective	NULL
studies	NULL
of	NULL
acute	NULL
non-lymphocytic	NULL
leukaemia	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Swedish	NULL
Cancer	NULL
Society	NULL
,	NULL
Karolinska	NULL
institutets	NULL
fonder	NULL
,	NULL
and	NULL
Magnus	NULL
Bergwalls	NULL
stiftelse	NULL
.	NULL

References	NULL
'	NULL
Hoffbrand	NULL
A	NULL
,	NULL
Ganeshaguru	NULL
K	NULL
,	NULL
Janossy	NULL
G	NULL
,	NULL
Greaves	NULL
MF	NULL
,	NULL
Catovsky	NULL
D	NULL
,	NULL
Woodruff	NULL
RK	NULL
.	NULL

Terminal	NULL
deoxynucleotidyl-transferase	NULL
levels	NULL
and	NULL
membrane	NULL
phenotypes	NULL
in	NULL
diagnosis	NULL
of	NULL
acute	NULL
leukaemia	NULL
.	NULL

Lancet	NULL
1977	NULL
;	NULL
ii	NULL
:	NULL
520-3	NULL
.	NULL

°	NULL
Ellis	NULL
RB	NULL
,	NULL
Rapson	NULL
NT	NULL
,	NULL
Patrick	NULL
AD	NULL
,	NULL
Greaves	NULL
MF	NULL
.	NULL

Expression	NULL
of	NULL
hexosaminidase	NULL
isoenzymes	NULL
in	NULL
childhood	NULL
leukemia	NULL
.	NULL

N	NULL
Eng	NULL
!	NULL

J	NULL
Med	NULL
1978	NULL
;	NULL
298	NULL
:476-80	NULL
.	NULL

1829	NULL
3	NULL
Marcus	NULL
SL	NULL
,	NULL
Smith	NULL
SW	NULL
,	NULL
Jarowski	NULL
CI	NULL
,	NULL
Modak	NULL
MJ	NULL
.	NULL

Terminal	NULL
deoxyribo-nucleotidyl	NULL
transferase	NULL
activity	NULL
in	NULL
acute	NULL
undifferentiated	NULL
leukaemia	NULL
.	NULL

Biochem	NULL
Biophys	NULL
Res	NULL
Commun	NULL
1976	NULL
;	NULL
570:37-44	NULL
.	NULL

*	NULL
Marks	NULL
MS	NULL
,	NULL
Boltimore	NULL
D	NULL
,	NULL
McCaffrey	NULL
R.	NULL
Terminal	NULL
transferase	NULL
as	NULL
a	NULL
predictor	NULL
of	NULL
initial	NULL
responsiveness	NULL
to	NULL
vincristine	NULL
and	NULL
prednisone	NULL
in	NULL
blastic	NULL
chronic	NULL
myelogenous	NULL
leukaemia	NULL
.	NULL

N	NULL
Eng	NULL
!	NULL

J	NULL
Med	NULL
1978	NULL
;	NULL
298:812-4	NULL
.	NULL

5	NULL
Quagliata	NULL
C	NULL
,	NULL
Gaig	NULL
D	NULL
,	NULL
Conklyn	NULL
M	NULL
,	NULL
Silber	NULL
R.	NULL
Studies	NULL
on	NULL
the	NULL
lymphocyte	NULL
5	NULL
'nucleotidase	NULL
in	NULL
chronic	NULL
lymphocytic	NULL
leukaemia	NULL
.	NULL

Infectious	NULL
mono-nucleosis	NULL
,	NULL
normal	NULL
subpopulations	NULL
and	NULL
phytohemaglutinin	NULL
stimulated	NULL
cells	NULL
.	NULL

Cancer	NULL
Res	NULL
1974	NULL
;	NULL
84:3197-202	NULL
.	NULL

®	NULL
Meir	NULL
J	NULL
,	NULL
Coleman	NULL
MS	NULL
,	NULL
Hutton	NULL
JJ	NULL
.	NULL

Adenosine	NULL
deaminase	NULL
activity	NULL
in	NULL
peripheral	NULL
blood	NULL
cells	NULL
of	NULL
patients	NULL
with	NULL
haematological	NULL
malignancies	NULL
.	NULL

Br	NULL
J	NULL
Cancer	NULL
1976	NULL
;	NULL
33:312-9	NULL
.	NULL

``	NULL
Yarbo	NULL
GSK	NULL
,	NULL
Lippman	NULL
ME	NULL
,	NULL
Johnson	NULL
GE	NULL
,	NULL
Leventhal	NULL
BG	NULL
.	NULL

Glucocorticoid	NULL
receptors	NULL
in	NULL
subpopulation	NULL
of	NULL
childhood	NULL
acute	NULL
lymphocytic	NULL
leukaemia	NULL
.	NULL

Cancer	NULL
Res	NULL
1977	NULL
;	NULL
87:2688-95	NULL
.	NULL

®	NULL
Kaplow	NULL
LS	NULL
.	NULL

Substitute	NULL
for	NULL
benzidine	NULL
in	NULL
myeloperoxidase	NULL
stains	NULL
.	NULL

Am	NULL
J	NULL
Clin	NULL
Pathol	NULL
1975	NULL
;	NULL
63:451	NULL
.	NULL

°	NULL
Lofflee	NULL
H.	NULL
Cytochemischer	NULL
Nachweis	NULL
von	NULL
unspezifischer	NULL
Esterase	NULL
in	NULL
Ausstrichen	NULL
Beitrige	NULL
zur	NULL
Technik	NULL
und	NULL
Ergebnisse	NULL
im	NULL
Blutausstrich	NULL
des	NULL
Menschen	NULL
.	NULL

Klin	NULL
Wochenschr	NULL
1961	NULL
;	NULL
39:1220-7	NULL
.	NULL

'°	NULL
Fischer	NULL
R	NULL
,	NULL
Schmalzl	NULL
F.	NULL
Uber	NULL
die	NULL
Hemmbarkeit	NULL
der	NULL
Esteraseaktivitit	NULL
in	NULL
Blutmonocyten	NULL
durch	NULL
Natriumfluorid	NULL
.	NULL

K/in	NULL
Wochenschr	NULL
1964	NULL
;	NULL
42:751	NULL
.	NULL

**	NULL
Moloney	NULL
WC	NULL
,	NULL
McPherson	NULL
K	NULL
,	NULL
Fliegelman	NULL
L.	NULL
Esterase	NULL
activity	NULL
in	NULL
leukocytes	NULL
demonstrated	NULL
by	NULL
the	NULL
use	NULL
of	NULL
naphthol	NULL
AS-D	NULL
chloroacetate	NULL
substrate	NULL
.	NULL

J	NULL
Histochem	NULL
Cytochem	NULL
1960	NULL
;	NULL
8:200-7	NULL
.	NULL

'*	NULL
Bennet	NULL
JM	NULL
,	NULL
Catovsky	NULL
D	NULL
,	NULL
Daniel	NULL
MT	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Proposals	NULL
for	NULL
the	NULL
classification	NULL
of	NULL
the	NULL
acute	NULL
leukaemias	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
1976	NULL
;	NULL
33:451-8	NULL
.	NULL

``	NULL
Burton	NULL
KA	NULL
.	NULL

A	NULL
study	NULL
of	NULL
the	NULL
conditions	NULL
and	NULL
mechanism	NULL
of	NULL
the	NULL
diphenylamine	NULL
reaction	NULL
for	NULL
the	NULL
colorimetric	NULL
estimation	NULL
of	NULL
deoxyribonucleic	NULL
acid	NULL
.	NULL

Biochem	NULL
J	NULL
1956	NULL
;	NULL
62:315-22	NULL
.	NULL

44	NULL
Lippman	NULL
ME	NULL
,	NULL
Halterman	NULL
RH	NULL
,	NULL
Leventhal	NULL
BG	NULL
,	NULL
Perry	NULL
S	NULL
,	NULL
Thompsson	NULL
EB	NULL
.	NULL

Glucocorticoid-binding	NULL
proteins	NULL
in	NULL
-	NULL
human	NULL
-	NULL
acute	NULL
lymphoblastic	NULL
leukaemic	NULL
blast	NULL
cells	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
1973	NULL
;	NULL
52:1715-25	NULL
.	NULL

5	NULL
Mertelsmann	NULL
R	NULL
,	NULL
Koziner	NULL
B	NULL
,	NULL
Ralph	NULL
P	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Evidence	NULL
for	NULL
district	NULL
lymphocytic	NULL
and	NULL
monocytic	NULL
populations	NULL
in	NULL
a	NULL
patient	NULL
with	NULL
terminal	NULL
transferase	NULL
positive	NULL
acute	NULL
leukaemia	NULL
.	NULL

Blood	NULL
1978	NULL
;	NULL
51:1051-6	NULL
.	NULL

(	NULL
Accepted	NULL
10	NULL
April	NULL
1981	NULL
)	NULL
Oral	NULL
contraceptive	NULL
steroid	NULL
plasma	NULL
concentrations	NULL
in	NULL
smokers	NULL
and	NULL
non-smokers	NULL
F	NULL
E	NULL
CRAWFORD	NULL
,	NULL
DJ	NULL
BACK	NULL
,	NULL
MLE	NULL
ORME	NULL
,	NULL
A	NULL
M	NULL
BRECKENRIDGE	NULL
Abstract	NULL
A	NULL
study	NULL
was	NULL
performed	NULL
to	NULL
find	NULL
out	NULL
whether	NULL
the	NULL
overall	NULL
rate	NULL
of	NULL
metabolism	NULL
of	NULL
oral	NULL
contraceptives	NULL
is	NULL
affected	NULL
by	NULL
smoking	NULL
and	NULL
whether	NULL
this	NULL
explains	NULL
the	NULL
increased	NULL
incidence	NULL
of	NULL
cardiovascular	NULL
disease	NULL
in	NULL
users	NULL
of	NULL
oral	NULL
contraceptives	NULL
who	NULL
smoke	NULL
.	NULL

Plasma	NULL
ethinyloestradiol	NULL
and	NULL
norgestrel	NULL
concentrations	NULL
in	NULL
311	NULL
women	NULL
using	NULL
oral	NULL
contraceptives	NULL
were	NULL
similar	NULL
in	NULL
smokers	NULL
and	NULL
non-smokers	NULL
.	NULL

The	NULL
overall	NULL
rate	NULL
of	NULL
metabolism	NULL
of	NULL
contraceptive	NULL
steroids	NULL
does	NULL
not	NULL
therefore	NULL
seem	NULL
to	NULL
be	NULL
affected	NULL
by	NULL
cigarette	NULL
smoking	NULL
.	NULL

Introduction	NULL
Cigarette	NULL
smoking	NULL
is	NULL
one	NULL
of	NULL
the	NULL
factors	NULL
implicated	NULL
in	NULL
the	NULL
development	NULL
of	NULL
cardiovascular	NULL
disease	NULL
in	NULL
oral	NULL
contraceptive	NULL
Department	NULL
of	NULL
Pharmacology	NULL
and	NULL
Therapeutics	NULL
,	NULL
University	NULL
of	NULL
Liverpool	NULL
,	NULL
Liverpool	NULL
L69	NULL
3BX	NULL
F	NULL
E	NULL
CRAWFORD	NULL
,	NULL
ssc	NULL
,	NULL
pub	NULL
,	NULL
postdoctoral	NULL
fellow	NULL
D	NULL
J	NULL
BACK	NULL
,	NULL
Bsc	NULL
,	NULL
PHD	NULL
,	NULL
lecturer	NULL
in	NULL
pharmacology	NULL
M	NULL
L	NULL
'	NULL
E	NULL
ORME	NULL
,	NULL
MA	NULL
,	NULL
FRCP	NULL
,	NULL
senior	NULL
lecturer	NULL
in	NULL
clinical	NULL
pharmacology	NULL
A	NULL
M	NULL
BRECKENRIDGE	NULL
,	NULL
msc	NULL
,	NULL
FRCP	NULL
,	NULL
professor	NULL
of	NULL
clinical	NULL
pharmacology	NULL
users	NULL
.	NULL
``	NULL

Tobacco	NULL
smoke	NULL
contains	NULL
over	NULL
3000	NULL
chemicals	NULL
and	NULL
some	NULL
of	NULL
the	NULL
constituents	NULL
(	NULL
polycyclic	NULL
aromatic	NULL
hydrocarbons	NULL
)	NULL
are	NULL
enzyme-inducers	NULL
.	NULL

In	NULL
pharmacokinetic	NULL
studies	NULL
the	NULL
rate	NULL
of	NULL
metabolism	NULL
of	NULL
some	NULL
drugs-for	NULL
example	NULL
,	NULL
phenacetin	NULL
and	NULL
antipyrine-is	NULL
increased	NULL
in	NULL
cigarette	NULL
smokers	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
no	NULL
effect	NULL
of	NULL
smoking	NULL
has	NULL
been	NULL
observed	NULL
on	NULL
the	NULL
disposition	NULL
of	NULL
other	NULL
drugs-for	NULL
example	NULL
,	NULL
diazepam	NULL
and	NULL
phenytoin	NULL
.	NULL
``	NULL

The	NULL
metabolism	NULL
of	NULL
ethinyloestradiol	NULL
may	NULL
be	NULL
important	NULL
in	NULL
relation	NULL
to	NULL
toxicity	NULL
:	NULL
a	NULL
metabolite	NULL
of	NULL
ethinyloestradiol	NULL
becomes	NULL
irreversibly	NULL
bound	NULL
to	NULL
protein	NULL
of	NULL
human	NULL
hepatic	NULL
microsomes	NULL
,	NULL
``	NULL
and	NULL
this	NULL
could	NULL
be	NULL
the	NULL
starting	NULL
point	NULL
of	NULL
an	NULL
immunological	NULL
mechanism	NULL
leading	NULL
to	NULL
an	NULL
adverse	NULL
reaction	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
,	NULL
anti-ethinyloestradiol	NULL
antibodies	NULL
have	NULL
been	NULL
detected	NULL
in	NULL
oral	NULL
contraceptive	NULL
users	NULL
.	NULL

The	NULL
aim	NULL
of	NULL
our	NULL
study	NULL
was	NULL
twofold	NULL
:	NULL
to	NULL
find	NULL
out	NULL
whether	NULL
oral	NULL
contraceptives	NULL
fall	NULL
into	NULL
the	NULL
group	NULL
of	NULL
drugs	NULL
whose	NULL
overall	NULL
rate	NULL
of	NULL
metabolism	NULL
is	NULL
affected	NULL
by	NULL
smoking	NULL
,	NULL
and	NULL
to	NULL
see	NULL
whether	NULL
this	NULL
might	NULL
account	NULL
for	NULL
the	NULL
increased	NULL
toxicity	NULL
.	NULL

Subjects	NULL
,	NULL
methods	NULL
,	NULL
and	NULL
results	NULL
We	NULL
studied	NULL
311	NULL
women	NULL
taking	NULL
oral	NULL
contraceptives	NULL
containing	NULL
30	NULL
ug	NULL
ethinyloestradiol	NULL
(	NULL
Eugynon	NULL
30	NULL
,	NULL
Microgynon	NULL
,	NULL
and	NULL
Ovranette	NULL
)	NULL
.	NULL

A	NULL
blood	NULL
sample	NULL
was	NULL
obtained	NULL
from	NULL
each	NULL
woman	NULL
,	NULL
and	NULL
we	NULL
recorded	NULL
the	NULL
time	NULL
of	NULL
the	NULL
last	NULL
pill	NULL
,	NULL
her	NULL
weight	NULL
,	NULL
age	NULL
,	NULL
whether	NULL
she	NULL
smoked	NULL
(	NULL
and	NULL
the	NULL
number	NULL
of	NULL
cigarettes	NULL
per	NULL
day	NULL
)	NULL
,	NULL
and	NULL
any	NULL
other	NULL
medication	NULL
.	NULL

Plasma	NULL

